Physiomics® is an oncology consultancy which offers a full suite of PK and PD services including: non-compartmental analysis, population PK, pharmacology based PK, pre-clinical and clinical PD modelling and systems biology modelling. We support clients of all sizes (such as Merck KGaA, Bicycle Therapeutics and CellCentric) in making smart development decisions by helping them visualise, analyse and interpret their data. We use industry standard tools such as NONMEM, our own proprietary Virtual Tumour™ platform and bespoke R models to predict the effects of cancer drugs and treatments and improve the success rate of drug discovery and development projects. We have significant broad experience in the field of cancer including immune-oncology, radiation and DNA damage/ repair agents.